|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
53,543,000 |
Market
Cap: |
11.50(B) |
Last
Volume: |
464,634 |
Avg
Vol: |
475,567 |
52
Week Range: |
$164.52 - $273.43 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 400 MIDCAP |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 456 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Charles River Laboratories International is a contract research organization. Co. has a laboratory animal medicine and science to develop a portfolio of discovery and safety assessment services. Co.'s segments include: Research Models and Services, which supplies research models to the drug development industry; Discovery and Safety Assessment (DSA), which provides DSA services, including in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development; Manufacturing Support, which ensure the safe production and release of products manufactured by Co.'s clients.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
7,942 |
11,192 |
Total Buy Value |
$0 |
$0 |
$1,447,725 |
$2,162,353 |
Total People Bought |
0 |
0 |
3 |
3 |
Total Buy Transactions |
0 |
0 |
3 |
5 |
Total Shares Sold |
1,636 |
31,084 |
49,996 |
92,833 |
Total Sell Value |
$374,194 |
$7,621,206 |
$11,292,577 |
$21,658,880 |
Total People Sold |
2 |
6 |
6 |
8 |
Total Sell Transactions |
2 |
11 |
16 |
28 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Foster James C |
Chairman, President and CEO |
|
2018-08-17 |
4 |
GD |
$0.00 |
$0 |
I/I |
3,677 |
0 |
|
- |
|
Smith David Ross |
Corporate Executive VP & CFO |
|
2018-08-13 |
4 |
AS |
$119.20 |
$149,948 |
D/D |
(1,249) |
12,441 |
|
- |
|
Smith David Ross |
Corporate Executive VP & CFO |
|
2018-08-13 |
4 |
OE |
$76.12 |
$95,074 |
D/D |
1,249 |
13,690 |
|
- |
|
Smith David Ross |
Corporate Executive VP & CFO |
|
2018-08-12 |
4 |
D |
$120.59 |
$40,639 |
D/D |
(337) |
12,441 |
|
- |
|
Molho Davide |
President & COO |
|
2018-07-24 |
4 |
AS |
$125.00 |
$2,346,625 |
D/D |
(18,773) |
17,155 |
|
- |
|
Molho Davide |
President & COO |
|
2018-07-24 |
4 |
OE |
$59.41 |
$942,448 |
D/D |
13,849 |
35,928 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2018-07-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
4,000 |
267,676 |
|
- |
|
Molho Davide |
President & COO |
|
2018-07-23 |
4 |
AS |
$125.00 |
$1,450,000 |
D/D |
(11,600) |
22,079 |
|
- |
|
Molho Davide |
President & COO |
|
2018-07-17 |
4 |
AS |
$120.00 |
$1,335,120 |
D/D |
(11,126) |
33,679 |
|
- |
|
Molho Davide |
President & COO |
|
2018-07-17 |
4 |
OE |
$76.67 |
$472,671 |
D/D |
6,165 |
44,805 |
|
- |
|
Girshick Birgit |
Corporate Executive VP |
|
2018-07-17 |
4 |
AS |
$119.90 |
$476,962 |
D/D |
(3,978) |
18,999 |
|
- |
|
Foster James C |
Chairman & CEO |
|
2018-07-02 |
4 |
AS |
$111.45 |
$309,540 |
D/D |
(2,775) |
271,676 |
|
- |
|
Foster James C |
Chairman & CEO |
|
2018-07-02 |
4 |
AS |
$110.64 |
$554,552 |
D/D |
(5,005) |
285,270 |
|
- |
|
Foster James C |
Chairman & CEO |
|
2018-07-02 |
4 |
AS |
$110.42 |
$707,472 |
D/D |
(6,401) |
290,275 |
|
- |
|
Foster James C |
Chairman & CEO |
|
2018-07-02 |
4 |
AS |
$111.25 |
$595,462 |
D/D |
(5,348) |
274,451 |
|
- |
|
Foster James C |
Chairman & CEO |
|
2018-07-02 |
4 |
AS |
$110.97 |
$607,865 |
D/D |
(5,471) |
279,799 |
|
- |
|
Massaro George |
Director |
|
2018-06-25 |
4 |
AS |
$112.76 |
$368,381 |
D/D |
(3,230) |
14,137 |
|
- |
|
Massaro George |
Director |
|
2018-06-25 |
4 |
OE |
$52.29 |
$184,584 |
D/D |
3,530 |
17,367 |
|
- |
|
Massaro George |
Director |
|
2018-06-25 |
4 |
AS |
$115.40 |
$34,665 |
D/D |
(300) |
13,837 |
|
- |
|
Foster James C |
Chairman & CEO |
|
2018-05-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,000 |
296,676 |
|
- |
|
Wallman Richard F |
Director |
|
2018-05-14 |
4/A |
A |
$0.00 |
$0 |
D/D |
653 |
26,905 |
|
- |
|
Kochevar Deborah Turner |
Director |
|
2018-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
2,004 |
10,490 |
|
- |
|
Mackay Martin |
Director |
|
2018-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
2,564 |
5,346 |
|
- |
|
Milne George M Jr |
Director |
|
2018-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
2,843 |
29,583 |
|
- |
|
Mangeolle Jean-Paul |
Director |
|
2018-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
2,004 |
2,004 |
|
- |
|
2069 Records found
|
|
Page 28 of 83 |
|
|